DOI:
10.1055/s-00000180
Journal of Neurological Surgery Part A: Central European Neurosurgery
LinksClose Window
References
Dummer R, Goldinger SM, Turtschi CP. , et al.
Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study.
Eur J Cancer 2014;
50 (03) 611-621
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.